PointState Capital’s Prothena Corp PRTA Stock Holding History

PointState Capital’s Portfolio PRTA Stock Details PRTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-245,890	Closed	-$9.22M	–	197
2017 Q4	$9.22M	Sell	245,890 -106,510	-30%	-$5.42M	0.09%	98
2017 Q3	$22.8M	Buy	352,400 +79,900	+29%	+$4.89M	0.19%	84
2017 Q2	$14.7M	Buy	+272,500	New	+$14.5M	0.16%	74
2016 Q4	–	Sell	-350,000	Closed	-$21M	–	155
2016 Q3	$21M	Buy	+350,000	New	+$18.8M	0.22%	76
2015 Q1	–	Sell	-400,000	Closed	-$8.3M	–	141
2014 Q4	$8.3M	Sell	400,000 -150,000	-27%	-$3.13M	0.14%	85
2014 Q3	$12.2M	Buy	+550,000	New	+$11.7M	0.22%	59
2014 Q2	–	Sell	-80,000	Closed	-$3.06M	–	152
2014 Q1	$3.06M	Buy	+80,000	New	+$2.58M	0.05%	95
2013 Q3	–	Sell	-14,089	Closed	-$182K	–	157
2013 Q2	$182K	Buy	+14,089	New	+$131K	﹤0.01%	127

Other funds holding PRTA

WIM

Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PointState Capital's PRTA Position: Q1 2018 in Review

PointState Capital sold out of Prothena Corp (PRTA) in Q1 2018, closing a stake of 245,890 shares — an estimated $9.22M sold.

PointState Capital first reported a position in PRTA in Q2 2013 and held it in 8 quarters. The position peaked at $22.8M in Q3 2017. 142 funds tracked by Wall St. Rank hold PRTA as of Q1 2018.

PointState Capital reported no remaining Prothena Corp position as of Q1 2018 after selling out during the quarter.
PointState Capital sold 245,890 Prothena Corp shares in Q1 2018, an estimated $9.22M.
PointState Capital first reported a position in Prothena Corp in Q2 2013 and held it in 8 quarters.
PointState Capital's Prothena Corp position peaked at $22.8M in Q3 2017.
142 funds tracked by Wall St. Rank held Prothena Corp as of Q1 2018.

Based on PointState Capital's 13F filing for Q1 2018, filed 15 May 2018.